Toronto Cardiac Tumour Conference

 

2020
38:29

Toronto Cardiac Tumour Conference

Discussion: Undifferentiated Spindle Cell Neoplasm Treatment Options from Chemotherapy to Radiation? 3D Models and Reconstruction and How They Help Surgeons Plan Their Procedures

FEATURING Albiruni Abdul, Azad Mashari, Brian Van Tine, Khalil Jawad, Robert Cusimano, Abha Gupta, Michael Farkouh, David Schultz
  • 21 views
  • September 9, 2020
04:12

Toronto Cardiac Tumour Conference

Case Presentation: Undifferentiated Spindle Cell Neoplasm Treated with Docorubicin and Ifosfamide

FEATURING Khalil Jawad
  • 16 views
  • September 8, 2020
05:20

Toronto Cardiac Tumour Conference

Case Presentation: Angiosarcoma Grade 3/3 with Mediastinal Lymphadenopathy and Bilateral Pulmonary Metastases

FEATURING Geoffrey Watson
  • 18 views
  • September 8, 2020
13:36

Toronto Cardiac Tumour Conference

Canadian Sarcoma Database (CanSARCC): Is There a Value in Creating a National Sarcoma Database?

FEATURING Abha Gupta
  • 21 views
  • September 8, 2020
34:39

Toronto Cardiac Tumour Conference

Discussion: Angiosarcoma Grade 3/3 with Mediastinal Lymphadenopathy and Bilateral Pulmonary Metastases Case. What Are the Chemotherapy Options? How Radioresponsive Is the Tumor?

FEATURING Albiruni Abdul, David B. Schultz, Azad Mashari, Brian Van Tine, Geoffrey Watson, Abha Gupta, Robert Cusimano, Michael Farkouh
  • 24 views
  • September 4, 2020
17:41

Toronto Cardiac Tumour Conference

Panel Discussion: Canadian Sarcoma Database (CanSARCC): How Can It Be Integrated in Other Institutions?

FEATURING Abha Gupta
  • 14 views
  • September 4, 2020
23:27

Toronto Cardiac Tumour Conference

Panel Discussion: The Importance of Starting a Cardiac Tumor Registry. What Are the Best Modalities of Radiotherapy in the Management of Cardiac Tumours?

FEATURING Michael Farkouh, David B. Schultz
  • 14 views
  • September 4, 2020
46:19

Toronto Cardiac Tumour Conference

Is There a Difference in Efficacy Between Doxorubicin Bolus and Infusion? Should We Start All Cardio Sarcoma Patients on Chemotherapy? What Is the Utility of 3D Imaging and How Can it Best Be Utilised?

FEATURING Azad Mashari, Robert Cusimano, Khalil Jawad, Geoffrey Watson, Robin Jones
  • 21 views
  • September 4, 2020
26:59

Toronto Cardiac Tumour Conference

Neoadjuvant Chemotherapy: Evidence, Rationale and Approach. Is Combination Chemotherapy preferred over Single Agent Chemo? Is a Combination of Adriamycin and Ifosfamide the Preffered First Line Agent?

FEATURING Vinod Ravi
  • 36 views
  • September 3, 2020
31:22

Toronto Cardiac Tumour Conference

Beyond Chemotherapy in Cardiac Sarcomas: What Histological Subtypes Are There? Is That the Answer to Treatment?

FEATURING Robin Jones
  • 15 views
  • September 3, 2020
13:50

Toronto Cardiac Tumour Conference

Adjuvant Therapies for Cardiac Malignancies: How Rare Are Cardiac Tumors? How Can We Improve Care of Patients with Cardiac Tumors?

FEATURING Robert Cusimano
  • 16 views
  • September 3, 2020
17:48

Toronto Cardiac Tumour Conference

The Role of Radiotherapy in the Management of Cardiac Tumours: Which Cardiac Tumors Are Treated with Radiation?

FEATURING David B. Schultz
  • 62 views
  • September 3, 2020
37:45

Toronto Cardiac Tumour Conference

Sarcoma Metabolism: What Metabolic Biomarkers Do We Have and What Therapies Are Available?

FEATURING Brian Van Tine
  • 28 views
  • September 3, 2020
28:37

Toronto Cardiac Tumour Conference

Patient-specific 3D Modeling of Cardiac Tumors: What Are the Basic Concepts and How Do You Create 3D Models from Medical Imaging Data?

FEATURING Azad Mashari
  • 132 views
  • September 3, 2020
16:47

Toronto Cardiac Tumour Conference

Adjuvant Therapies in Cardiac Sarcomas: What Shold Be the Standard of Treatment? Why Do Patients Have a Metastatis Relapse after Initial Successful treatment?

FEATURING Albiruni Abdul
  • 12 views
  • September 3, 2020